GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolife Sciences Inc (OTCPK:BLFE) » Definitions » Accounts Receivable

Biolife Sciences (Biolife Sciences) Accounts Receivable : $0.14 Mil (As of May. 2008)


View and export this data going back to 2005. Start your Free Trial

What is Biolife Sciences Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Biolife Sciences's accounts receivables for the quarter that ended in May. 2008 was $0.14 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Biolife Sciences's Days Sales Outstanding for the quarter that ended in May. 2008 was 7.26.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Biolife Sciences's Net-Net Working Capital per share for the quarter that ended in May. 2008 was $-631.00.


Biolife Sciences Accounts Receivable Historical Data

The historical data trend for Biolife Sciences's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolife Sciences Accounts Receivable Chart

Biolife Sciences Annual Data
Trend Nov04 Nov05 Nov06 Nov07
Accounts Receivable
- 0.02 0.32 0.16

Biolife Sciences Quarterly Data
Nov04 Feb05 May05 Aug05 Nov05 Feb06 May06 Aug06 Nov06 Feb07 May07 Aug07 Nov07 Feb08 May08
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.26 0.15 0.16 0.16 0.14

Biolife Sciences Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Biolife Sciences Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Biolife Sciences's Days Sales Outstanding for the quarter that ended in May. 2008 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0.143/1.798*91
=7.26

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Biolife Sciences's accounts receivable are only considered to be worth 75% of book value:

Biolife Sciences's Net-Net Working Capital Per Share for the quarter that ended in May. 2008 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0.04+0.75 * 0.143+0.5 * 0-3.46
-0-0)/0.00525
=-631.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Biolife Sciences Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Biolife Sciences's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Biolife Sciences (Biolife Sciences) Business Description

Traded in Other Exchanges
N/A
Address
2831 Street Rose Parkway, No. 200, Henderson, NV, USA, 89052
Biolife Sciences Inc is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The company's technologies include antimicrobial copper air filters and copper-infused textiles. Its revenues are primarily generated from the sale of sanitation products.
Executives
Arthur Viola director, 10 percent owner, officer: CEO

Biolife Sciences (Biolife Sciences) Headlines

From GuruFocus

Rhino Novi Announces Name Change and New CEO

By Marketwired Marketwired 09-15-2020